Atrial Fibrillation Clinical Trials in Örebro
3 recruitingÖrebro, Sweden
Showing 1–3 of 3 trials
Recruiting
Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Anthos Therapeutics, Inc.1,900 enrolled721 locationsNCT05712200
Recruiting
Phase 3
RECURrence of Atrial Fibrillation After Cardioversion of Patients Randomized to Dapagliflozin or Usual Care
Atrial Fibrillation (AF)
Region Stockholm1,600 enrolled7 locationsNCT07187570
Recruiting
Phase 3
SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF
Atrial FibrillationChronic Coronary Syndrome
Region Örebro County800 enrolled8 locationsNCT05852704